期刊文献+

Concise synthesis of dopexamine dihydrochloride via benzyl protecting protocol

Concise synthesis of dopexamine dihydrochloride via benzyl protecting protocol
原文传递
导出
摘要 Benzyl protecting protocol was first employed in two routes for the concise synthesis of dopexamine dihydrochloride.This protecting group could be cleanly removed under mild condition and no unacceptable ion was brought to the final product.The total yield of route I was 43.8% from phenylacetic acid,while it was 54.1% of route II from 2-(3,4-bis(benzyloxy)phenyl)acetic acid.The titration purity of the final product was more than 99.5%,while any single or total impurities met the known standard of the drug by HPLC analysis.The measured residual palladium met an acceptable limit(〈1 ppm) as an API for injection. Benzyl protecting protocol was first employed in two routes for the concise synthesis of dopexamine dihydrochloride.This protecting group could be cleanly removed under mild condition and no unacceptable ion was brought to the final product.The total yield of route I was 43.8% from phenylacetic acid,while it was 54.1% of route II from 2-(3,4-bis(benzyloxy)phenyl)acetic acid.The titration purity of the final product was more than 99.5%,while any single or total impurities met the known standard of the drug by HPLC analysis.The measured residual palladium met an acceptable limit(〈1 ppm) as an API for injection.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2015年第3期357-360,共4页 中国化学快报(英文版)
基金 supported by Program for Innovative Research Team of the Ministry of Education and Program for Liaoning Innovative Research Team in University Shenyang Shuangding Pharmaceutical Co.,LTD.,Shenyang,China
关键词 removed protecting titration palladium concise benzyl dissolved concentrated acetic brought removed protecting titration palladium concise benzyl dissolved concentrated acetic brought
  • 相关文献

参考文献7

  • 1O. Olejnik, Pharmaceutical formulations, EP0117033A2, 1984.
  • 2T. Meinertz, H. Drexler, H. Just, Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation? Basic Res. Cardiol. 84 (1989) 177-186.
  • 3R.A. Brown, J. Dixon, J.B. Farmer, et al., Dopexamine: a novel agonist at peripheral dopamine receptors and b2-adrenoceptors, Br. J. Pharm. 85 (1985) 599-608.
  • 4C.V. Leier, P.F. Binkley, J. Carpenter, et al., Cardiovascular pharmacology of dopexamine in low output congestive heart failure, Am. J. Cardiol. 62 (1988) 94-99.
  • 5B.D. Gres, C. Flamens, M.C. Gruner, The use of dopexamine hydrochloride in patients with low cardiac output after cardiac surgery, J. Cardiothorac. Anest. 3 (1989) 16-19.
  • 6F.C. Colardyn, J.F. Vandenbogaerde, D.P. Vogelaers, et al., Use of dopexamine hydrochloride in patients with septic shock, Crit. Care Med. 17 (1989) 999-1003.
  • 7J. Lu, Y. Ma, L. Mo, et al., Synthesis of dopexamine, J. China Pharm. Univ. 30 (1999) 328-331.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部